MUSTANG BIO, INC. (MBIO)

PriceLoading quote

Financial charts

Revenue

No reported data

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Research & development$7.6M$40.5M$62.5M$49.9M$37.2M$30.0M$21.1M$7.9M$2.5M
Operating expenses$2.4M$16.2M$49.3M$76.2M$66.7M$56.8M$45.9M$31.2M$31.8M$11.4M
Operating income−$2.4M−$16.2M−$49.3M−$76.2M−$66.7M−$56.8M−$45.9M−$31.2M−$31.8M−$11.4M
Net income−$1.9M−$15.8M−$51.6M−$77.5M−$66.4M−$60.0M−$46.4M−$30.7M−$31.3M−$12.7M
Basic EPSper diluted share-$0.39-$38.57-$299.95-$10.09-$0.76-$1.14-$1.29-$1.14-$1.24-$1.15
Diluted EPSper diluted share-$0.39-$38.57-$299.95-$10.09-$0.76-$1.14-$1.29-$1.14-$1.24-$1.15

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys1$237.12 disclosed value
Sells (SEC code S)2$240.92 disclosed value
3 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 30, 2025Form 4Herskowitz NeilDirectorSellCOMMON STOCK, PAR VALUE $0.0001247$0.96$237.12145
Dec 30, 2025Form 4Chill Adam J.DirectorSellCOMMON STOCK, PAR VALUE $0.00014$0.95$3.80375
Dec 30, 2025Form 4Jin DavidDirectorBuyCOMMON STOCK, PAR VALUE $0.0001247$0.96$237.12286